Linda U. Krebs

Linda U. Krebs

Auto-generated profile, based on publicly available information

Linda U. Krebs

International Society of Nurses in Cancer Care, Vancouver, Canada

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2019 in Health Expectations
Verified
Journal Article
Open access
PDF file
BABonnie Addario
Bonnie Addario
JGJan Geissler
Jan Geissler
MHMarcia K. Horn
Marcia K. Horn
LKLinda U. Krebs
Linda U. Krebs
DMDeborah Maskens
Deborah Maskens
NWNicole Willmarth
Nicole Willmarth
Context: Patient‐reported outcomes (PROs) are used in parallel with clinical evidence to inform decisions made by industry, clinicians, regulators, health technology assessment bodies and other health‐care decision‐makers. In addition, PRO data can also guide shared decision making and individual patient choice. Yet, the quality of many PROs in cancer clinical trials is suboptimal and requires improvement to add value to health care and policy decision making.Objective: To show how the integration of the patient and/or patient advocate at all stages of PRO development can help to realize the full potential of PROs.Methods: We examined the literature to show that the patient voice is often absent from the planning and implementation of PROs in cancer clinical trials. Good practice examples from the literature were combined with guideline recommendations, training or educational resources, and our own experience to create detailed practical steps for the inclusion of patients and/or patient advocates throughout PRO development.Results: Patient or patient advocates can play an active role in shaping PROs that are meaningful to the patient. They can contribute to content, choice of medium and implementation in a way that may support PRO completion and minimize missing data. Patients and their advocates can work to ensure PRO findings are disseminated appropriately in a way that is accessible to patients.Conclusion: This practical guidance aims to optimize PRO development and implementation in clinical trials, resulting in robust, relevant data that reflect the patient experience and that support decisions made by all stakeholders involved in research and health care.

26 July 2023 in The Patient - Patient-Centered Outcomes Research
Verified
Journal Article
Open access
PDF file
BABonnie Addario
Bonnie Addario
VAVioleta Astratinei
Violeta Astratinei
LBLouise Binder
Louise Binder
JGJan Geissler
Jan Geissler
MHMarcia K. Horn
Marcia K. Horn
ASAndrew Spiegel
Andrew Spiegel
The increased use of telehealth in cancer care during the coronavirus disease 2019 pandemic has added to our knowledge and experience of the modality with benefits in terms of efficacy, cost, and patient and healthcare professional experience reported. However, telehealth has also been found not to be universally available to all patients with cancer, nor to be appropriate for every healthcare interaction; additionally, not all patients prefer it. Now that coronavirus disease restrictions have essentially ended and an opportunity to re-assess telehealth provision in cancer care presents, we offer a framework that aims to ensure that the needs and preferences of the patient community are included in the development of telehealth provision. Stakeholders in this process include patients, patient advocates, healthcare providers, healthcare services commissioners, managers, and policy makers. The framework outlines how patient advocates can work with other stakeholders as equal partners at all stages of telehealth service development. The patient advocate community has a unique understanding of the patient perspective as well as expertise in healthcare design and delivery. This enables advocates to contribute to shaping telehealth provision, from policy and guideline formulation to patient navigation. Appropriate resources, education and training may be needed for all stakeholders to support the development of an effective telehealth system. Together with other stakeholders, patient advocates can make an important contribution to optimizing appropriate patient-centred telehealth provision in cancer care.

17 June 2011 in Journal of Cancer Education
Verified
Journal Article
Closed access
PDF file
LBLinda Burhansstipanov
Linda Burhansstipanov
JOJoseph O’donnell
Joseph O’donnell
RPRoberta Paisano
Roberta Paisano
LKLinda U. Krebs
Linda U. Krebs
JKJudith Salmon Kaur
Judith Salmon Kaur
MLMary P. Lovato
Mary P. Lovato